Intra Cellular Therapies | ITCI - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Intra Cellular Therapies

Intra Cellular Therapies reported $75.73M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 290.9M 176.05M
ALKERMES ALKS:US USD 321.4M 28.93M
BioCryst Pharmaceuticals BCRX:US USD 401.59M 96.82M
Biogen BIIB:US USD 2.9B 521.1M
Bristol-Myers Squibb BMY:US USD 9B 128M
Cytokinetics CYTK:US USD 765.58M 700M
Esperion Therapeutics ESPR:US USD 144.91M 20.14M
Gilead Sciences GILD:US USD 7.2B 430M
Halozyme Therapeutics HALO:US USD 96.38M 137.81M
Intra Cellular Therapies ITCI:US USD 75.73M 72.89M
J&J JNJ:US USD 3.36B 2B
Marinus Pharmaceuticals MRNS:US USD 146.9M 93.65M
Minerva Neurosciences NERV:US USD 35.98M 116K
Nektar Therapeutics NKTR:US USD 76.96M 11.27M
Neurocrine Biosciences NBIX:US USD 103.8M 159.1M
Novartis NVS:US USD 12B 4.48B
Prothena PRTA:US USD 686.18M 24.22M
RedHill Biopharma RDHL:US USD 19.97M 4.76M
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
United Therapeutics UTHR:US USD 1.16B 202.3M
Vanda Pharmaceuticals VNDA:US USD 354.17M 219.14M